GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Blueprint Medicines Corp (FRA:2L9) » Definitions » E10

Blueprint Medicines (FRA:2L9) E10 : €-4.95 (As of Mar. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Blueprint Medicines E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Blueprint Medicines's adjusted earnings per share data for the three months ended in Mar. 2024 was €1.288. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €-4.95 for the trailing ten years ended in Mar. 2024.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2024-06-15), Blueprint Medicines's current stock price is €99.48. Blueprint Medicines's E10 for the quarter that ended in Mar. 2024 was €-4.95. Blueprint Medicines's Shiller PE Ratio of today is .


Blueprint Medicines E10 Historical Data

The historical data trend for Blueprint Medicines's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Blueprint Medicines E10 Chart

Blueprint Medicines Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -5.05

Blueprint Medicines Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - -5.35 -5.05 -4.95

Competitive Comparison of Blueprint Medicines's E10

For the Biotechnology subindustry, Blueprint Medicines's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Blueprint Medicines's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Blueprint Medicines's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Blueprint Medicines's Shiller PE Ratio falls into.



Blueprint Medicines E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Blueprint Medicines's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=1.288/131.7762*131.7762
=1.288

Current CPI (Mar. 2024) = 131.7762.

Blueprint Medicines Quarterly Data

per share eps CPI Adj_EPS
201406 -0.539 100.560 -0.706
201409 -0.701 100.428 -0.920
201412 -1.015 99.070 -1.350
201503 -0.514 99.621 -0.680
201506 -0.722 100.684 -0.945
201509 -0.419 100.392 -0.550
201512 -0.532 99.792 -0.703
201603 -0.512 100.470 -0.672
201606 -0.623 101.688 -0.807
201609 -0.552 101.861 -0.714
201612 -0.711 101.863 -0.920
201703 -0.785 102.862 -1.006
201706 -0.765 103.349 -0.975
201709 -0.805 104.136 -1.019
201712 -1.039 104.011 -1.316
201803 -1.046 105.290 -1.309
201806 -0.531 106.317 -0.658
201809 -1.423 106.507 -1.761
201812 -1.609 105.998 -2.000
201903 -1.752 107.251 -2.153
201906 -1.805 108.070 -2.201
201909 -1.752 108.329 -2.131
201912 -1.215 108.420 -1.477
202003 -1.910 108.902 -2.311
202006 -2.025 108.767 -2.453
202009 9.475 109.815 11.370
202012 -1.258 109.897 -1.508
202103 -1.445 111.754 -1.704
202106 -1.544 114.631 -1.775
202109 -1.700 115.734 -1.936
202112 -4.779 117.630 -5.354
202203 -1.625 121.301 -1.765
202206 -2.535 125.017 -2.672
202209 -2.252 125.227 -2.370
202212 -2.502 125.222 -2.633
202303 -2.008 127.348 -2.078
202306 -2.021 128.729 -2.069
202309 -2.061 129.860 -2.091
202312 -1.669 129.419 -1.699
202403 1.288 131.776 1.288

Add all the adjusted EPS together and divide 10 will get our e10.


Blueprint Medicines  (FRA:2L9) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Blueprint Medicines E10 Related Terms

Thank you for viewing the detailed overview of Blueprint Medicines's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Blueprint Medicines (FRA:2L9) Business Description

Traded in Other Exchanges
Address
45 Sidney Street, Cambridge, MA, USA, 02139
Blueprint Medicines Corp is a biopharmaceutical company. It is focused on improving the lives of patients with diseases driven by abnormal kinase activation. The company has developed a small molecule drug pipeline in cancer and a rare genetic disease. Its drug candidates BLU-285, which targets KIT Exon 17 mutants and PDGFRa D842V, abnormally active receptor tyrosine kinase mutants that are drivers of cancer and proliferative disorders. Its other drug candidate is BLU 554 FOR Advanced Hepatocellular Carcinoma, and BLU-667 for Ret Mutations, Fusions, and Predicted Resistant Mutants.

Blueprint Medicines (FRA:2L9) Headlines

No Headlines